Literature DB >> 891593

Differences in the binding of drugs to plasma proteins from newborn and adult man. II.

H Kurz, H Michels, H H Stickel.   

Abstract

The binding of certain drugs to isolated fractions of plasma proteins obtained from newborn and adult man has been studied by equilibrium dialysis. For thiopental, desipramine, nitrofurantoin, sulfamethoxydiazine, meticillin and salicylic acid no difference was found between binding to the albumin fraction from newborns and adults. However, for thiopental, desipramine and promethazine binding to the globulin fraction was smaller in the newborns than in adults. Addition of bilirubin to the albumin fraction decreased the binding of nitrofurantoin, sulfamethoxydiazine and meticillin. No difference in the binding of meticillin to the albumin or globulin fractions from newborns and adults was found. The binding decreased, however, if both fractions were combined. Four mechanisms to explain the difference in binding between newborns and adults are discussed: (1) Displacement of drugs by bilirubin, (2) different binding properties of cord and adult albumin, (3) different properties of the globulins and (4) interaction of albumin with globulins in the newborn.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 891593     DOI: 10.1007/bf00562941

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  6 in total

1.  The maximum F-ratio as a short-cut test for heterogeneity of variance.

Authors:  H O HARTLEY
Journal:  Biometrika       Date:  1950-12       Impact factor: 2.445

2.  Differences in the binding of drugs to plasma proteins from newborn and adult man. I.

Authors:  H Kurz; A Mauser-Ganshorn; H H Stickel
Journal:  Eur J Clin Pharmacol       Date:  1977-07-19       Impact factor: 2.953

3.  Drug-protein binding in the newborn infant.

Authors:  J Krasner; G P Giacoia; S J Yaffe
Journal:  Ann N Y Acad Sci       Date:  1973-11-26       Impact factor: 5.691

4.  The binding of sulfaphenazole to fetal, neonatal, and adult human plasma albumin.

Authors:  C F Chignell; E S Vesell; D K Starkweather; C M Berlin
Journal:  Clin Pharmacol Ther       Date:  1971 Nov-Dec       Impact factor: 6.875

5.  Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration.

Authors:  H Kurz; H Trunk; B Weitz
Journal:  Arzneimittelforschung       Date:  1977-07

6.  Characteristic properties of fetal human albumin (Alb F) in isomerization equilibrium.

Authors:  K Miyoshi; K Saijo; Y Kotani; T Kashiwagi; H Kawai
Journal:  Tokushima J Exp Med       Date:  1966-11
  6 in total
  11 in total

Review 1.  Plasma protein binding of drugs in pregnancy and in neonates.

Authors:  L J Notarianni
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

2.  [Pharmaco-kinetic aspects of protein-binding (author's transl)].

Authors:  H Kurz
Journal:  Klin Wochenschr       Date:  1978-12-15

Review 3.  Clinical pharmacology of the perinatal period and early infancy.

Authors:  P L Morselli
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

Review 4.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

Review 5.  Pharmacodynamics and pharmacokinetics of thiopental.

Authors:  H Russo; F Bressolle
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

6.  Protein binding predictions in infants.

Authors:  Patrick J McNamara; Jane Alcorn
Journal:  AAPS PharmSci       Date:  2002

Review 7.  Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients.

Authors:  B J Anderson; A D McKee; N H Holford
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 8.  Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations.

Authors:  J H Kanto
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

9.  Chloramphenicol pharmacokinetics in hospitalized patients.

Authors:  J R Koup; A H Lau; B Brodsky; R L Slaughter
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

10.  Naloxone protein binding in adult and foetal plasma.

Authors:  L A Asali; K F Brown
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.